| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $36.7M | -11.4% |
| Cost of Revenue | $26.4M | +10.2% |
| Gross Profit | $10.3M | -41.1% |
| R&D Expense | $5.6M | -28.0% |
| SG&A Expense | $25.4M | -10.1% |
| Operating Income | -$35.6M | +28.4% |
| Pre-tax Income | -$37.1M | +24.9% |
| Income Tax | -$298K | +84.5% |
| Net Income | -$36.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.5M | -32.6% |
| Accounts Receivable | $3.9M | -7.3% |
| Inventory | $11.6M | -5.3% |
| Current Assets | $45.7M | -25.3% |
| Total Assets | $128.6M | -15.5% |
| Current Liabilities | $8.9M | -18.4% |
| Long-term Debt | $13.3M | -39.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.8M | +31.3% |
| Capital Expenditures | $7.9M | -71.8% |
| Investing Cash Flow | -$7.7M | +72.5% |
| Financing Cash Flow | $12.8M | +24.7% |
| Free Cash Flow | -$26.7M | +51.8% |
| +22.5% |
| EPS (Basic) | -$1.16 | +31.4% |
| EPS (Diluted) | -$1.16 | +31.4% |
| Total Liabilities |
| $38.6M |
| -26.4% |
| Stockholders' Equity | $90.0M | -9.9% |